Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Ezekowitz

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
Stroke|May 3, 2014
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationWalter N Kernan, Bruce Ovbiagele, Henry R Black, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillationTaku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
The New England Journal of Medicine|November 21, 2013
Edoxaban versus warfarin in patients with atrial fibrillationRobert P Giugliano, Christian T Ruff, Eugene Braunwald, et al.
American Heart Journal|December 11, 2017
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registriesBenjamin A Steinberg, Haiyan Gao, Peter Shrader, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
Stroke|May 3, 2014
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationWalter N Kernan, Bruce Ovbiagele, Henry R Black, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillationTaku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
The New England Journal of Medicine|November 21, 2013
Edoxaban versus warfarin in patients with atrial fibrillationRobert P Giugliano, Christian T Ruff, Eugene Braunwald, et al.
American Heart Journal|December 11, 2017
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registriesBenjamin A Steinberg, Haiyan Gao, Peter Shrader, et al.
Pageof 19